Smith Hunter C sold RYTM
February 12, 2026 · Form 4 insider transaction
Smith Hunter C sold 100 shares of Rhythm Pharmaceuticals, Inc. at $100.10 per share, a transaction worth $10.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
100
Price
$100.10
Total value
$10.0K
InsiderSmith Hunter C
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 12, 2026
Filing dateFebruary 12, 2026
Shares owned after118,466
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025.